Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
53 patents granted to the 5 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Vyome Holdings, Inc.’s names, not what it holds today.
Patents granted
53
52 utility, 1 reissue, 1976 to Dec 31, 2025
Granted in 2025
4
Against 3 in 2024 and 4 in 2023
Applications published
80
7 of them in 2025
Names they are printed under
5
a former name, a subsidiary
By yearGrantedApplications published
'10'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology14
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name5 counted
Obalon Therapeutics, Inc. a former name
US, as the owner printed on each patent
32 granted
14 publishedObalon Therapeutics, Inc. a former name
named as the applicant on its applications, in US
0 granted
39 publishedRESHAPE LIFESCIENCES INC. a former name
US, as the owner printed on each patent
19 granted
3 publishedRESHAPE LIFESCIENCES, INC. a former name
named as the applicant on its applications, in US
0 granted
19 publishedVYOME THERAPEUTICS LIMITED a subsidiary
IN, as the owner printed on each patent
2 granted
5 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Oct 14, 2025 | 12,440,358 | Pressure control system for intragastric device | Medical technology | RESHAPE LIFESCIENCES INC. |
| Jul 8, 2025 | 12,350,179 | Intragastric device | Medical technology | RESHAPE LIFESCIENCES INC. |
| Jun 17, 2025 | 12,329,972 | High-frequency low duty cycle patterns for nerual regulation | Medical technology | RESHAPE LIFESCIENCES INC. |
| May 27, 2025 | 12,311,174 | Simultaneous multi-site vagus nerve neuromodulation for improved glycemic control system and methods | Medical technology | RESHAPE LIFESCIENCES INC. |
| Oct 1, 2024 | 12,102,547 | Intragastric volume-occupying device and method for fabricating same | Medical technology | RESHAPE LIFESCIENCES INC. |
| Sep 17, 2024 | 12,090,075 | Intragastric device | Medical technology | RESHAPE LIFESCIENCES INC. |
| May 7, 2024 | 11,974,934 | Intragastric device | Medical technology | RESHAPE LIFESCIENCES INC. |
| Nov 21, 2023 | 11,819,433 | Pressure control system for intragastric device | Medical technology | RESHAPE LIFESCIENCES INC. |
| Oct 10, 2023 | 11,779,482 | Intragastric device | Medical technology | RESHAPE LIFESCIENCES INC. |
| Aug 29, 2023 | 11,737,899 | Intragastric device | Medical technology | RESHAPE LIFESCIENCES INC. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 18, 2025 | 2025/0381404 | HIGH-FREQUENCY LOW DUTY CYCLE PATTERNS FOR NEURAL REGULATION | Medical technology | RESHAPE LIFESCIENCES, INC. |
| Sep 25, 2025 | 2025/0295920 | SIMULTANEOUS MULTI-SITE VAGUS NERVE NEUROMODULATION FOR IMPROVED GLYCEMIC CONTROL SYSTEM AND METHODS | Medical technology | RESHAPE LIFESCIENCES INC. |
| Aug 28, 2025 | 2025/0269182 | INTERMITTENT DUAL VAGUS NEUROMODULATION TREATMENT FOR IMPROVED GLYCEMIC CONTROL IN TYPE 2 DIABETES | Medical technology | RESHAPE LIFESCIENCES, INC. |
| Aug 14, 2025 | 2025/0256105 | NEUROMODULATION OF TWO OR MORE NEURONAL TARGETS IN TREATMENT OF A MEDICAL CONDITION | Medical technology | RESHAPE LIFESCIENCES INC. |
| Aug 7, 2025 | 2025/0249248 | VAGUS NERVE NEUROMODULATION FOR THE TREATMENT OF THE HYPOGLYCEMIC STATE | Medical technology | RESHAPE LIFESCIENCES, INC. |
| Jul 24, 2025 | 2025/0235338 | INTRAGASTRIC DEVICE | Medical technology | RESHAPE LIFESCIENCES, INC. |
| Jul 17, 2025 | 2025/0228684 | INTRAGASTRIC VOLUME-OCCUPYING DEVICE AND METHOD FOR FABRICATING SAME | Medical technology | RESHAPE LIFESCIENCES, INC. |
| Sep 26, 2024 | 2024/0315860 | PRESSURE CONTROL SYSTEM FOR INTRAGASTRIC DEVICE | Medical technology | RESHAPE LIFESCIENCES, INC. · patent 12,440,358 granted from it |
| May 9, 2024 | 2024/0148531 | SYSTEMS AND METHODS FOR DETERMINING FAILURE OF INTRAGASTRIC DEVICES | Medical technology | RESHAPE LIFESCIENCES, INC. |
| Jan 18, 2024 | 2024/0016635 | INTRAGASTRIC DEVICE | Medical technology | RESHAPE LIFESCIENCES, INC. · patent 11,974,934 granted from it |
What it applied for, 2024 to 2025: Medical technology 10.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.